Variables | Non-hepatic inflow occlusion | Hepatic inflow occlusion | p-value |
---|---|---|---|
n = 100 | n = 103 | ||
Gender (%) | Â | Â | 0.104 |
 Male | 85 (85.0) | 95 (92.2) |  |
 Female | 15 (15.0) | 8 (7.8) |  |
Age (y) | 43.9 ± 11.7 | 42.8 ± 11.4 | 0.498 |
Length (%) | Â | Â | 0.437 |
  ≤ 5 cm | 26 (26.0) | 22 (21.4) |  |
  > 5 cm | 74 (74.0) | 81 (78.6) |  |
Tumor number(%) | Â | Â | 0.397 |
 Single | 81 (81.0) | 78 (75.7) |  |
 Multiple | 19 (19.0) | 25 (24.3) |  |
BCLC stage (%) | Â | Â | 0.009 |
 A | 67 (67.0) | 49 (47.6) |  |
 B | 20 (20.0) | 25 (24.3) |  |
 C | 13 (13.0) | 29 (28.2) |  |
Child–Pugh (%) |  |  | 0.219 |
 A | 84 (84.0) | 79 (76.7) |  |
 B | 16 (16.0) | 24 (23.3) |  |
AFP (%) | Â | Â | 0.470 |
  ≤ 400 ng/ml | 39 (39.0) | 35 (34.0) |  |
  > 400 ng/ml | 61 (61.0) | 68 (66.0) |  |
Edmondson-steiner(%) | Â | Â | 0.057 |
 I | 13 (13.0) | 8 (7.8) |  |
 II | 36 (36.0) | 54 (52.4) |  |
 III | 33 (33.0) | 21 (20.4) |  |
 IV | 18 (18.0) | 20 (19.4) |  |
Necrosis (%) | Â | Â | 0.086 |
 No | 68 (68.0) | 81 (78.6) |  |
 Yes | 32 (32.0) | 22 (21.4) |  |
Local invasion (%) | Â | Â | 0.437 |
 No | 46 (46.0) | 53 (51.5) |  |
 Yes | 54 (54.0) | 50 (48.5) |  |
ALB(g/L) | 35.2 (32.3–38.6) | 35.9 (33.1–38.8) | 0.516 |
ALT(U/L) | 27.0 (21.0–41.0) | 28.0 (21.0–41.0) | 0.548 |
AST(U/L) | 36.5 (28.0–61.3) | 37.0 (24.0–66.0) | 0.919 |
ALP(U/L) | 76.0 (56.0–93.0) | 75.0 (61.0–93.0) | 0.223 |
GGT(U/L) | 47.0 (28.3–91.0) | 58.0 (36.0–129.0) | 0.074 |
HBsAg(%) | Â | Â | 0.078 |
 No | 17 (17.0) | 9 (8.7) |  |
 Yes | 83 (83.0) | 94 (91.3) |  |